UDI and 21 CFR Part 801 Labeling for Imported Devices
What U.S. device labeling must contain, how UDI applies to imported devices, and where relabeling programs usually break down.
Labeling is the most visible artifact of compliance and the easiest to underestimate. A European label with the right technical content can still fail U.S. review because it lacks the name and place of business of the manufacturer, packer or distributor, uses symbols not recognized under U.S. requirements, or carries a UDI that was never submitted to GUDID.
What 21 CFR Part 801 requires
U.S. device labeling must identify the name and place of business of the manufacturer, packer or distributor, state the quantity of contents where applicable, and carry adequate directions for use. For an imported device distributed under a partner, the label typically needs to state that the device is distributed by that U.S. entity alongside the foreign manufacturer.
- Name and place of business of the manufacturer, packer or distributor.
- Statement of identity and net quantity of contents where required.
- Adequate directions for use, or a prescription statement where applicable.
- Any required warnings, contraindications and storage conditions.
- UDI carrier and human-readable UDI where the device class requires it.
UDI: the label, the barcode and GUDID
UDI compliance has three parts that fail independently: the device identifier and production identifier on the label, the machine-readable carrier, and the GUDID record describing the device. A scannable barcode with no GUDID submission is not compliant, and a GUDID record whose attributes do not match the physical label is worse, because it is discoverable.
- Confirm the UDI requirement and compliance date for your device class.
- Choose an issuing agency and allocate the device identifier before artwork is finalized.
- Validate the barcode in print at the smallest label size you will actually use.
- Submit and maintain the GUDID record, including updates on label or packaging changes.
Relabeling an imported device
When a U.S.-specific label is required, relabeling must happen under a documented procedure at a registered establishment, with traceability to the lot and a record of who performed the work and against which label revision. A label applied by an unregistered third party creates two problems at once: no controlled record and no clear establishment accountability.
Where labeling programs usually break
The recurring failure is version control between the artwork, the quality system and the warehouse. A revision is approved, the artwork is updated, but the picking process still has the prior cartons at the front of the shelf. The fix is procedural: label revision tied to lot, a line-clearance step, and a first-article check before a run begins.
Need this applied to your device?
We run U.S. entry, warehousing, fulfillment and post-market support for medical device manufacturers. Bring the specifics and we will map the steps.